Ftse Mib
35.366,37
0,61%
DAX
18.869,36
0,78%
S&P 500
5.308,19
1,17%
NASDAQ
16.741,54
1,40%
Bitcoin
66.119,06
7,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Chinook Therapeutics Inc (KDNY) Chinook Therapeutics Inc (KDNY) Notizie

Chinook Therapeutics Inc

KDNY
40,39
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
21/8/202319:21EDGAR2Form 15-12G - Securities registration termination [Section..
17/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202323:02EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/8/202322:39EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/8/202322:35EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202322:31EDGAR2Form 8-K - Current report
11/8/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:06EDGAR2Form 8-K - Current report
02/8/202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202313:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/7/202314:15EDGAR2Form 8-K - Current report
28/7/202314:00GLOBEChinook Therapeutics Announces First Patient Enrolled in..
26/7/202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/7/202322:01EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
17/6/202313:15GLOBEChinook Therapeutics Presents Data from CHK-336 Phase 1..
12/6/202322:00GLOBEChinook Therapeutics to Present Updated Data from Zigakibart..
12/6/202316:40DJNTrending: Novartis Buying Chinook Therapeutics for Up to..
12/6/202314:09DJNFlurry of European Companies Engaged in Acquisitions, Asset..
12/6/202307:53DJNNovartis to Acquire Chinook Therapeutics for Up to $3.5..
12/6/202307:00GLOBEChinook Therapeutics Enters into Agreement to be Acquired by..
16/5/202314:00GLOBEChinook Therapeutics Announces Partnership with Ionis to..
Apertura: Min: Max:
Chiusura: 40,39

La tua Cronologia

NASDAQ
KDNY
Chinook Therapeutics
ASX
FXUKOM
BIT
UI380C
Unicredit Bank
TG
COZ
Cognizant Tech Sol A
BITMOT
888030
Romania Tf 2,75% Ap41 Eur
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network